GS-6620

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-6620, covering 2012-03-26 to 2012-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection [Phase 1]

See pricing